Development Program Funding. As consideration for, and to partially fund the costs to be incurred by EXEL for, the research activities to be conducted by EXEL for the intended benefit of GSK pursuant to the Development Program, GSK shall pay the following research and development payments (collectively, the “Research and Development Payments”):
Appears in 1 contract
Sources: Product Development and Commercialization Agreement (Exelixis, Inc.)
Development Program Funding. As consideration for, and to partially fund the costs to be incurred by EXEL for, the research activities to be conducted by EXEL for the intended benefit of GSK pursuant to the Development Program, GSK shall pay the following research and development payments (collectively, the “Research and Development Payments”"RESEARCH AND DEVELOPMENT PAYMENTS"):
Appears in 1 contract
Sources: Product Development and Commercialization Agreement (Exelixis Inc)